Skip to content

A Pragmatic, Randomized Clinical Trial of Coronavirus (COVID-19) Vaccinations in Uveitis

A Pragmatic, Randomized Clinical Trial of Coronavirus (COVID-19) Vaccinations in Uveitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049467
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-02
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uveitis

Interventions

Experimental group1:prompt vaccination strategies
Experimental group2:deferred vaccination strategies

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Not vaccinated before screening; 3. Diagnosed with any form of uveitis in any eye; 4. Inactive disease state (all of the following are met): (1)<=0.5+ anterior chamber cells; (2)<=0.5+ vitreous opacity; (3) No active inflammatory choroidal or retinal vascular disease.

Exclusion criteria

Exclusion criteria: 1. Complete remission of uveitis: no active disease 3 months after discontinuation of all ophthalmic treatment; 2. Any known contraindications to the vaccine provided according to the manufacturing instructions: (1) Individuals with a history of hypersensitivity to any vaccine component; (2) Individuals whose body temperature exceeds 38.5 degree; (3) Pregnancy. 3. Any other situation that, in the opinion of the investigator, would put the subject at risk due to participation in this study.

Design outcomes

Primary

MeasureTime frame
time to worsening uveitis;

Countries

China

Contacts

Public ContactYang Peizeng

the First Affiliated Hospital of Chongqing Medical University

peizengycmu@126.com+86 13708349782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026